- Home
- IH vs KPTI Comparison
IH vs KPTI Comparison
Compare IH & KPTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | IH | KPTI |
|---|---|---|
| Founded | 1996 | 2008 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 116.0M | 172.6M |
| IPO Year | 2020 | 2013 |
Fundamental Metrics
Financial Performance| Metric | IH | KPTI |
|---|---|---|
| Price | $1.99 | $8.38 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $17.50 |
| AVG Volume (30 Days) | 8.1K | ★ 616.4K |
| Earning Date | 03-27-2026 | 02-12-2026 |
| Dividend Yield | ★ 4.25% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $146,067,000.00 |
| Revenue This Year | $39.02 | N/A |
| Revenue Next Year | N/A | $46.62 |
| P/E Ratio | $7.30 | ★ N/A |
| Revenue Growth | N/A | ★ 0.57 |
| 52 Week Low | $1.67 | $3.51 |
| 52 Week High | $3.60 | $10.99 |
Technical Indicators
Market Signals| Indicator | IH | KPTI |
|---|---|---|
| Relative Strength Index (RSI) | 58.27 | 49.01 |
| Support Level | $1.74 | $5.60 |
| Resistance Level | $2.05 | $8.95 |
| Average True Range (ATR) | 0.12 | 0.73 |
| MACD | 0.01 | -0.17 |
| Stochastic Oscillator | 85.43 | 41.91 |
Price Performance
Historical ComparisonAbout IH iHuman Inc.
iHuman Inc is a Chinese company that uses artificial intelligence to create technology-driven puzzle products for children, making parenting easier and children happier. The company offers a range of intellectual development products that are designed to make the child-rearing experience more manageable for parents while turning intellectual development into a fun journey for children. Its revenue is generated from subscription fees paid by users for premium content on their self-directed and interactive online applications, as well as offline products and other sources.
About KPTI Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc is a commercial-stage pharmaceutical company focused on novel cancer therapies and dedicated to the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company conducts research focused on intracellular communication between the nucleus and cytoplasm and has developed small-molecule compounds that inhibit exportin 1 (XPO1), a nuclear export protein. It is focused on marketing XPOVIO (selinexor).